{"title_page": "Amersham plc", "text_new": "{{EngvarB|date=September 2013}}\n{{Use dmy dates|date=September 2013}}\n\n{{Infobox company\n| name               = Amersham plc\n| logo               = Amershamlogo.PNG\n| former_name        = The Radiochemical Centre at Amersham<br />The Radiochemical Centre Ltd<br />Amersham International plc\n| type               = [[Privately held company|Private]]\n| foundation         = {{Start date and age|1946}}\n| defunct            = {{Start date and age|2003}}\n| location           = \n| location_city      = [[Amersham]], [[Buckinghamshire]]\n| location_country   = [[United Kingdom]]\n| key_people         = \n| industry           = [[Health care]]\n| products           = \n| revenue            = \n| operating_income   = \n| net_income         = \n| num_employees      = \n| fate               = Acquired by [[GE Healthcare]]\n| subsid             = \n| homepage           = \n| footnotes          = \n}}\n\n'''Amersham plc''' was a manufacturer of [[radiopharmaceutical]] products, to be used in diagnostic and therapeutic [[nuclear medicine]] procedures. The company became [[GE Healthcare]] following a takeover in 2003, which is based at the original site in [[Amersham]], [[Buckinghamshire]].\n\n==History==\nChilcote House in Amersham was first used for extraction of [[radium]] from radium concentrates in 1940, under [[Walter Patrick Grove]]. Over the next four years over 500 [[kilograms]] of [[radium bromide]] was produced, to be used to make luminous dials and instruments.<ref name=\"AmMuseum\">{{cite web |last1=Clutterbuck |first1=John |title=Amersham's Modern Alchemists |url=https://amershammuseum.org/history/research/trades-industries/alchemists/ |website=Amersham Museum |accessdate=6 November 2018}}</ref> In 1946 the facility was taken over by the [[Ministry of Supply]] and it became known as the \u201cnational centre for the processing and distribution of radium, radon and artificial radioactive substances for scientific, medical and industrial purposes\u201d.<ref name=\"JLCR\">{{cite journal |last1=Kitson |first1=Sean L. |title=Amersham radiochemistry to GE Healthcare |journal=Journal of Labelled Compounds and Radiopharmaceuticals |date=August 2007 |volume=50 |issue=9-10 |pages=737\u2013745 |doi=10.1002/jlcr.1427}}</ref> With a new focus on healthcare and industrial applications, the site was expanded and by 1949 when the name changed to \"The Radiochemical Centre (TRC), Amersham\", production included radium gas capsules for cancer treatment and [[carbon-14]]. The following year it became an outstation of the [[Atomic Energy Research Establishment]] (UKAERA) at Harwell, processing materials produced in its reactors.<ref name=\"AmMuseum\" /><ref name=hse>{{Cite journal|url=http://www.hse.gov.uk/nuclear/psrrep5.htm|title=The findings of NII's assessment of Amersham plc's 'site' periodic safety review|date=April 2002|publisher=HM Nuclear Installations Inspectorate|accessdate=12 June 2009|postscript=<!--None-->}}</ref>\n\nBy the 1960s, TRC had over 1000 catalogue items, using over 100 isotopes and exporting to 60 countries. A [[cyclotron]] was installed, the first for medical isotope production.<ref name=\"JLCR\" /> With restructuring of the UKAERA in 1971, TRC became a [[limited company]].<ref name=going-critical>{{cite book|url=http://www.waltpatterson.org/goingcritical.pdf|title=Going Critical: An Unofficial History of British Nuclear Power|author=[[Walter C. Patterson]]|publisher=Paladin|year=1985|isbn=0-586-08516-5|accessdate=12 June 2009}}</ref> By this time TRC had several international subsidiaries, and in 1976 work began on a second production site in [[Cardiff]]. \n\nThe Radiochemical Centre Limited became Amersham International Limited in 1981 and was the first company to be privatised by the Thatcher Government <ref name=\"AmMuseum\" /> in 1982 under the new name Amersham International plc.<ref name=\"hse\" /> It was the first privatisation in which the government sold 100% of its shares in a company. The offer was 24.6 times subscribed, meaning the share price rose from 142p per share to 188p per share by closing on the first day.<ref>{{Cite web|url=https://www.parliament.uk/documents/commons/lib/research/briefings/RP-Temp/RP14-061.pdf|title=House of Commons Library Research Paper|last=|first=|date=2014|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> The government retained a special share, allowing the veto of any outsourcing attempts, until it was redeemed in 1988. \n\nIn the early 1990s, the in-vitro diagnostic assay business was [[divested]] to a joint venture with [[Eastman Kodak]] called Amerlite Diagnostics Ltd, this was later wholly acquired by Eastman Kodak and renamed Kodak Clinical Diagnostics Ltd. This business was sold by Kodak to [[Johnson & Johnson]] and became known as Johnson & Johnson Clinical Diagnostics Ltd. The business is now called [[Ortho-Clinical Diagnostics]] Ltd.\n\nIn 1997 [[Pharmacia]] Biotech ([[Sweden]]), then owned by [[Pharmacia & Upjohn]], was fused with Amersham Life Science and renamed Amersham Pharmacia Biotech.<ref name=history>{{cite web|url=http://www.amersham.com/about/heritage.html |title=Amersham plc \u2013 Our Heritage|accessdate=2 February 2004 |archiveurl = https://web.archive.org/web/20040202095721/http://www.amersham.com/about/heritage.html |archivedate = 2 February 2004}}</ref> The Pharmacia name of this subsidiary was later dropped when Pharmacia & Upjohn sold its share of the company to Amersham plc, and changed its name to Amersham Biosciences in 2001.\n\nIn 1997, Amersham merged with [[Nycomed]] ([[Norway]])<ref name=history/> to form ''Nycomed Amersham plc''. In 1999, the Nycomed Pharma subsidiary was sold to [[Nordic Capital]], and in 2001 ''Nycomed Amersham plc'' was renamed to ''Amersham plc''.\n\nIn 2004, Amersham was acquired by the American firm [[General Electric]] (GE) and incorporated into the [[GE Healthcare]] business segment.<ref>{{cite news|url=http://news.bbc.co.uk/1/hi/business/3179954.stm|title=General Electric buys Amersham|date=10 October 2003|publisher=[[BBC]]|accessdate=12 June 2009}}</ref>\n\n==Operations==\nThe global headquarters of [[GE Healthcare]] is in [[Little Chalfont]] (near Amersham).{{fact|date=March 2020}} It is the first GE business unit headquarters outside the United States.{{fact|date=March 2020}}\n\nIn 2018 part of the company's {{convert|30|acre|adj=on|lk=on}} Cardiff site was sold for redevelopment as operations consolidated into a smaller area.<ref>{{cite news |last1=Barry |first1=Sion |title=Huge GE Healthcare site in Cardiff acquired in a \u00a318m deal |url=https://www.walesonline.co.uk/business/commercial-property/huge-ge-healthcare-site-cardiff-14510160 |work=walesonline |date=28 May 2018}}</ref>\n\nAmersham's former business segments became [[GE Healthcare]] Medical Analogy\u2019s and GP Healthcare Life Sequences\n\n==See also==\n* [[Pharmaceutical industry in the United Kingdom]]\n\n==References==\n{{reflist}}\n\n== External links ==\n* [https://web.archive.org/web/20040131010409/http://www.amersham.com/ 2004 archive copy of Amersham plc website]\n\n{{Pharmaceutical and biotechnology industry in the United Kingdom}}\n\n[[Category:Amersham]]\n[[Category:British companies established in 1946]]\n[[Category:Pharmaceutical companies of the United Kingdom]]\n[[Category:Companies formerly listed on the London Stock Exchange]]\n[[Category:Companies based in Buckinghamshire]]\n[[Category:1946 establishments in England]]\n[[Category:Pharmaceutical companies established in 1946]]\n", "text_old": "{{EngvarB|date=September 2013}}\n{{Use dmy dates|date=September 2013}}\n\n{{Infobox company\n| name               = Amersham plc\n| logo               = Amershamlogo.PNG\n| former_name        = The Radiochemical Centre at Amersham<br />The Radiochemical Centre Ltd<br />Amersham International plc\n| type               = [[Privately held company|Private]]\n| foundation         = {{Start date and age|1946}}\n| defunct            = {{Start date and age|2003}}\n| location           = \n| location_city      = [[Amersham]], [[Buckinghamshire]]\n| location_country   = [[United Kingdom]]\n| key_people         = \n| industry           = [[Health care]]\n| products           = \n| revenue            = \n| operating_income   = \n| net_income         = \n| num_employees      = \n| fate               = Acquired by [[GE Healthcare]]\n| subsid             = \n| homepage           = \n| footnotes          = \n}}\n\n'''Amersham plc''' was a manufacturer of [[radiopharmaceutical]] products, to be used in diagnostic and therapeutic [[nuclear medicine]] procedures. The company became [[GE Healthcare]] following a takeover in 2003, which is based at the original site in [[Amersham]], [[Buckinghamshire]].\n\n==History==\nChilcote House in Amersham was first used for extraction of [[radium]] from radium concentrates in 1940, under [[Walter Patrick Grove]]. Over the next four years over 500 [[kilograms]] of [[radium bromide]] was produced, to be used to make luminous dials and instruments.<ref name=\"AmMuseum\">{{cite web |last1=Clutterbuck |first1=John |title=Amersham's Modern Alchemists |url=https://amershammuseum.org/history/research/trades-industries/alchemists/ |website=Amersham Museum |accessdate=6 November 2018}}</ref> In 1946 the facility was taken over by the [[Ministry of Supply]] and it became known as the \u201cnational centre for the processing and distribution of radium, radon and artificial radioactive substances for scientific, medical and industrial purposes\u201d.<ref name=\"JLCR\">{{cite journal |last1=Kitson |first1=Sean L. |title=Amersham radiochemistry to GE Healthcare |journal=Journal of Labelled Compounds and Radiopharmaceuticals |date=August 2007 |volume=50 |issue=9-10 |pages=737\u2013745 |doi=10.1002/jlcr.1427}}</ref> With a new focus on healthcare and industrial applications, the site was expanded and by 1949 when the name changed to \"The Radiochemical Centre (TRC), Amersham\", production included radium gas capsules for cancer treatment and [[carbon-14]]. The following year it became an outstation of the [[Atomic Energy Research Establishment]] (UKAERA) at Harwell, processing materials produced in its reactors.<ref name=\"AmMuseum\" /><ref name=hse>{{Cite journal|url=http://www.hse.gov.uk/nuclear/psrrep5.htm|title=The findings of NII's assessment of Amersham plc's 'site' periodic safety review|date=April 2002|publisher=HM Nuclear Installations Inspectorate|accessdate=12 June 2009|postscript=<!--None-->}}</ref>\n\nBy the 1960s, TRC had over 1000 catalogue items, using over 100 isotopes and exporting to 60 countries. A [[cyclotron]] was installed, the first for medical isotope production.<ref name=\"JLCR\" /> With restructuring of the UKAERA in 1971, TRC became a [[limited company]].<ref name=going-critical>{{cite book|url=http://www.waltpatterson.org/goingcritical.pdf|title=Going Critical: An Unofficial History of British Nuclear Power|author=[[Walter C. Patterson]]|publisher=Paladin|year=1985|isbn=0-586-08516-5|accessdate=12 June 2009}}</ref> By this time TRC had several international subsidiaries, and in 1976 work began on a second production site in [[Cardiff]]. \n\nThe Radiochemical Centre Limited became Amersham International Limited in 1981 and was the first company to be privatised by the Thatcher Government <ref name=\"AmMuseum\" /> in 1982 under the new name Amersham International plc.<ref name=\"hse\" /> It was the first privatisation in which the government sold 100% of its shares in a company. The offer was 24.6 times subscribed, meaning the share price rose from 142p per share to 188p per share by closing on the first day.<ref>{{Cite web|url=https://www.parliament.uk/documents/commons/lib/research/briefings/RP-Temp/RP14-061.pdf|title=House of Commons Library Research Paper|last=|first=|date=2014|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> The government retained a special share, allowing the veto of any outsourcing attempts, until it was redeemed in 1988. \n\nIn the early 1990s, the in-vitro diagnostic assay business was [[divested]] to a joint venture with [[Eastman Kodak]] called Amerlite Diagnostics Ltd, this was later wholly acquired by Eastman Kodak and renamed Kodak Clinical Diagnostics Ltd. This business was sold by Kodak to [[Johnson & Johnson]] and became known as Johnson & Johnson Clinical Diagnostics Ltd. The business is now called [[Ortho-Clinical Diagnostics]] Ltd.\n\nIn 1997 [[Pharmacia]] Biotech ([[Sweden]]), then owned by [[Pharmacia & Upjohn]], was fused with Amersham Life Science and renamed Amersham Pharmacia Biotech.<ref name=history>{{cite web|url=http://www.amersham.com/about/heritage.html |title=Amersham plc \u2013 Our Heritage|accessdate=2 February 2004 |archiveurl = https://web.archive.org/web/20040202095721/http://www.amersham.com/about/heritage.html |archivedate = 2 February 2004}}</ref> The Pharmacia name of this subsidiary was later dropped when Pharmacia & Upjohn sold its share of the company to Amersham plc, and changed its name to Amersham Biosciences in 2001.\n\nIn 1997, Amersham merged with [[Nycomed]] ([[Norway]])<ref name=history/> to form ''Nycomed Amersham plc''. In 1999, the Nycomed Pharma subsidiary was sold to [[Nordic Capital]], and in 2001 ''Nycomed Amersham plc'' was renamed to ''Amersham plc''.\n\nIn 2004, Amersham was acquired by the American firm [[General Electric]] (GE) and incorporated into the [[GE Healthcare]] business segment.<ref>{{cite news|url=http://news.bbc.co.uk/1/hi/business/3179954.stm|title=General Electric buys Amersham|date=10 October 2003|publisher=[[BBC]]|accessdate=12 June 2009}}</ref>\n\n==Operations==\nThe global headquarters of [[GE Healthcare]] is in [[Little Chalfont]] (near Amersham).{{fact|date=March 2020}} It is the first GE business unit headquarters outside the United States.{{fact|date=March 2020}}\n\nIn 2018 part of the company's {{convert|30|acre|adj=on|lk=on}} Cardiff site was sold for redevelopment as operations consolidated into a smaller area.<ref>{{cite news |last1=Barry |first1=Sion |title=Huge GE Healthcare site in Cardiff acquired in a \u00a318m deal |url=https://www.walesonline.co.uk/business/commercial-property/huge-ge-healthcare-site-cardiff-14510160 |work=walesonline |date=28 May 2018}}</ref>\n\nAmersham's former business segments became [[GE Healthcare]] Medical Diagnostics and GE Healthcare Life Sciences.\n\n==See also==\n* [[Pharmaceutical industry in the United Kingdom]]\n\n==References==\n{{reflist}}\n\n== External links ==\n* [https://web.archive.org/web/20040131010409/http://www.amersham.com/ 2004 archive copy of Amersham plc website]\n\n{{Pharmaceutical and biotechnology industry in the United Kingdom}}\n\n[[Category:Amersham]]\n[[Category:British companies established in 1946]]\n[[Category:Pharmaceutical companies of the United Kingdom]]\n[[Category:Companies formerly listed on the London Stock Exchange]]\n[[Category:Companies based in Buckinghamshire]]\n[[Category:1946 establishments in England]]\n[[Category:Pharmaceutical companies established in 1946]]\n", "name_user": "81.111.171.107", "label": "unsafe", "comment": "(\u2192\u200eOperations)", "url_page": "//en.wikipedia.org/wiki/Amersham_plc"}
